Welcome to our dedicated page for FB Bancorp /MD/ SEC filings (Ticker: FBLA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on FB Bancorp /MD/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into FB Bancorp /MD/'s regulatory disclosures and financial reporting.
FB Bancorp, Inc. (FBLA) Chief Financial Officer share purchase disclosed. The CFO reported buying 66 shares of FB Bancorp common stock on 11/17/2025 at a price of $12.14 per share. After this transaction, the officer directly owns 8,236 shares. In addition, there are indirect holdings of 8,441 shares through a 401(k) plan and 802 shares through an ESOP, as noted in the filing. A footnote explains that certain transactions reflected in these balances were not required to be reported under Section 16 of the Securities Exchange Act of 1934.
FB Bancorp, Inc. authorized a share repurchase program to buy back up to 1,983,750 shares of its common stock. The company notes this equals approximately 10% of shares currently outstanding.
The authorization outlines a maximum amount the company may repurchase; execution details are referenced in a press release dated November 13, 2025.
FB Bancorp (FBLA) reported a return to profitability for the quarter ended September 30, 2025. Net income was $1.1 million (EPS $0.06), compared with a net loss of $0.9 million a year ago. Net interest income rose to $13.6 million as interest expense declined year over year, while noninterest expense moderated.
Total assets reached $1.26 billion, deposits were $839.9 million, and loans held for investment, net, were $753.8 million. Securities available for sale were $298.3 million, with accumulated other comprehensive loss improving to $(7.5) million from $(16.2) million at year-end. Mortgage banking remained a contributor, with $4.0 million in quarterly gains on loan sales.
Credit quality was stable to mixed: the allowance for credit losses stood at $6.2 million, and nonaccrual loans were $14.5 million. Capital remained strong; the Bank was categorized as well capitalized with a CET1 ratio of 28.52% and a Tier 1 leverage ratio of 20.05%. Common shares outstanding were 19,837,500 as of November 11, 2025.
FB Bancorp, Inc. (FBLA) calls its 2025 annual meeting for December 9, 2025 at 2:00 p.m. local time at Fidelity Bank’s main office in New Orleans. This is the first annual meeting since the company’s initial public offering in October 2024. Stockholders of record at the close of business on October 6, 2025 may vote; 19,837,500 shares of common stock were outstanding as of that date, with one vote per share and a 10% voting cap under the Articles for holders exceeding that level.
Three proposals are up for vote: (1) elect three directors (plurality standard); (2) approve the FB Bancorp, Inc. 2025 Equity Incentive Plan (majority of votes cast); and (3) ratify EisnerAmper LLP as independent registered public accounting firm (majority of votes cast). Brokers lack discretion on Items 1 and 2 but may vote uninstructed shares on Item 3.
Key Plan details: the proposed 2025 Equity Incentive Plan has a share reserve of 2,777,250 shares, comprised of 793,500 for restricted stock/RSUs (4% limit) and 1,983,750 for stock options (10% limit). If approved, initial awards to each non‑employee director will self‑execute: 29,756 restricted shares (valued at $357,370 as disclosed) and 74,390 stock options per director, vesting over five years. The Plan becomes effective December 9, 2025 and no awards may be granted after December 8, 2035.